Cargando…

Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts

Essential oils and aromatic extracts (oleoresins, absolutes, concretes, resinoids) are often used as food flavorings and constituents of fragrance compositions. The flavor and fragrance industry observed significant growth in the sales of some natural materials during the COVID-19 outbreak. Some com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strub, Daniel Jan, Talma, Michał, Strub, Maria, Rut, Wioletta, Zmudzinski, Mikolaj, Brud, Władysław, Neyts, Johan, Vangeel, Laura, Zhang, Linlin, Sun, Xinyuanyuan, Lv, Zongyang, Nayak, Digant, Olsen, Shaun K., Hilgenfeld, Rolf, Jochmans, Dirk, Drąg, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392441/ https://www.ncbi.nlm.nih.gov/pubmed/35987981 http://dx.doi.org/10.1038/s41598-022-18676-w

Ejemplares similares

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL(pro) and M(pro) proteases, and nsp14 guanine N7-methyltransferase
por: Zmudzinski, Mikolaj, et al.
Publicado: (2023)

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
por: Rut, Wioletta, et al.
Publicado: (2020)

Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes
por: Rut, Wioletta, et al.
Publicado: (2020)

A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease
por: Patchett, Stephanie, et al.
Publicado: (2021)

Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
por: Cooper, Mark S., et al.
Publicado: (2022)

Cytotoxicity, early safety screening, and antimicrobial potential of minor oxime constituents of essential oils and aromatic extracts
por: Surowiak, Alicja Karolina, et al.
Publicado: (2022)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease †
por: Göhl, Matthias, et al.
Publicado: (2022)

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
por: Lv, Zongyang, et al.
Publicado: (2022)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
por: Zhang, Linlin, et al.
Publicado: (2020)

Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study
por: Nawrot-Hadzik, Izabela, et al.
Publicado: (2021)

H172Y mutation perturbs the S1 pocket and nirmatrelvir binding of SARS-CoV-2 main protease through a nonnative hydrogen bond
por: de Oliveira, Vinicius Martins, et al.
Publicado: (2022)

Synthesis, Structure–Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication
por: Bardiot, Dorothée, et al.
Publicado: (2022)

The path towards effective antivirals against rabies
por: Jochmans, Dirk, et al.
Publicado: (2019)

Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding
por: Perlinska, Agata P., et al.
Publicado: (2022)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase
por: Kasprzyk, Renata, et al.
Publicado: (2021)

SARS-CoV-2 M(pro) Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
por: Chen, Sizhu Amelia, et al.
Publicado: (2023)

Intervention strategies for emerging viruses: use of antivirals
por: Debing, Yannick, et al.
Publicado: (2013)

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2012)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
por: Poreba, Marcin, et al.
Publicado: (2018)

An Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease
por: Clayton, Joseph, et al.
Publicado: (2023)

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
por: Chiu, Winston, et al.
Publicado: (2023)

Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
por: Persoons, Leentje, et al.
Publicado: (2021)

Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells
por: Vanhoutte, Roeland, et al.
Publicado: (2023)

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
por: Do, Thuc Nguyen Dan, et al.
Publicado: (2021)

SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells
por: Do, Thuc Nguyen Dan, et al.
Publicado: (2022)

Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families
por: Poreba, Marcin, et al.
Publicado: (2017)

Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives
por: El Mansouri, Az-eddine, et al.
Publicado: (2022)

Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6
por: Yuan, Lingmin, et al.
Publicado: (2022)

A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2011)

Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
por: Gao, Shenghua, et al.
Publicado: (2022)

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Antiviral strategies to control calicivirus infections
por: Rohayem, Jacques, et al.
Publicado: (2010)

Structural insights into the mechanism and E2 specificity of the RBR E3 ubiquitin ligase HHARI
por: Yuan, Lingmin, et al.
Publicado: (2017)

Crystal structures of an E1–E2–ubiquitin thioester mimetic reveal molecular mechanisms of transthioesterification
por: Yuan, Lingmin, et al.
Publicado: (2021)

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment
por: Abdelnabi, Rana, et al.
Publicado: (2023)

Structural basis for the indispensable role of a unique zinc finger motif in LNX2 ubiquitination
por: Nayak, Digant, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_civg1ahpa65li6nk9d145rbbtn